MedKoo Cat#: 562389 | Name: TY-52156
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TY-52156 is a S1P3 receptor antagonist. TY-52156 inhibited both the S1P-induced increase in [Ca(2+)](i) and Rho activation. In contrast, VPC23019 and JTE013 inhibited only the increase in [Ca(2+)](i) and Rho activation, respectively. TY-52156 inhibited FTY-720-induced S1P(3) receptor-mediated bradycardia in vivo. TY-52156 is both sensitive and useful as an S1P(3) receptor-specific antagonist and reveal that S1P induces vasoconstriction by directly activating S1P(3) receptor and through a subsequent increase in [Ca(2+)](i) and Rho activation in vascular smooth muscle cells.

Chemical Structure

TY-52156
TY-52156
CAS#934369-14-9

Theoretical Analysis

MedKoo Cat#: 562389

Name: TY-52156

CAS#: 934369-14-9

Chemical Formula: C18H19Cl2N3O

Exact Mass: 363.0905

Molecular Weight: 364.27

Elemental Analysis: C, 59.35; H, 5.26; Cl, 19.46; N, 11.54; O, 4.39

Price and Availability

Size Price Availability Quantity
25mg USD 250.00 2 Weeks
50mg USD 450.00 2 Weeks
100mg USD 750.00 2 Weeks
200mg USD 1,250.00 2 Weeks
500mg USD 2,650.00 2 Weeks
1g USD 3,450.00 2 Weeks
2g USD 5,750.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
TY-52156; TY 52156; TY52156;
IUPAC/Chemical Name
N-(4-Chlorophenyl)-3,3-dimethyl-2-oxobutanimidic 2-(4-chlorophenyl) hydrazide
InChi Key
DBVLAHOFMRUWIC-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H19Cl2N3O/c1-18(2,3)16(24)17(21)23(15-10-6-13(20)7-11-15)22-14-8-4-12(19)5-9-14/h4-11,21-22H,1-3H3
SMILES Code
CC(C)(C)C(C(N(C1=CC=C(Cl)C=C1)NC2=CC=C(Cl)C=C2)=N)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 364.27 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Liu D, Liu J, Li Y, Du L, Cao Q, Yang L, Zhou Y, Chen P, Guo Y, Zeng G, DiSanto ME, Hu W, Zhang X. Broad and diverse roles of sphingosine-1-phosphate/sphingosine-1-phosphate receptors in the prostate. iScience. 2024 Oct 30;27(12):111290. doi: 10.1016/j.isci.2024.111290. PMID: 39618500; PMCID: PMC11607605. 2: Peng J, Tang R, He J, Yu Q, Wang D, Qi D. S1PR3 inhibition protects against LPS-induced ARDS by inhibiting NF-κB and improving mitochondrial oxidative phosphorylation. J Transl Med. 2024 Jun 5;22(1):535. doi: 10.1186/s12967-024-05220-9. PMID: 38840216; PMCID: PMC11151509. 3: Prasad VP, Wagner S, Keul P, Hermann S, Levkau B, Schäfers M, Haufe G. Synthesis, radiosynthesis and biochemical evaluation of fluorinated analogues of sphingosine-1-phosphate receptor 3 specific antagonists using PET. Bioorg Med Chem. 2024 Apr 15;104:117697. doi: 10.1016/j.bmc.2024.117697. Epub 2024 Mar 26. PMID: 38599005. 4: Wu J, Liang Y, Fu P, Feng A, Lu Q, Unwalla HJ, Marciano DP, Black SM, Wang T. Sphingosine-1-Phosphate Receptor 3 Induces Endothelial Barrier Loss via ADAM10-Mediated Vascular Endothelial-Cadherin Cleavage. Int J Mol Sci. 2023 Nov 8;24(22):16083. doi: 10.3390/ijms242216083. PMID: 38003272; PMCID: PMC10671260. 5: Roggeri A, Olivero G, Usai C, Vanmierlo T, Pittaluga A. Presynaptic Release- Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720. Cells. 2023 Sep 24;12(19):2343. doi: 10.3390/cells12192343. PMID: 37830557; PMCID: PMC10571862. 6: Zhu D, Jiang T, Ma D, Zhang H, Zhang J, Lv W, Gong M, Wang H, Liu Z, Su H, Zeng L, Liu S, Tang S, Yang B, Tshavuka FI, Fu G, Liu Z, Peng D, Liu H, Yan Z, Cao Z, Zhao H, He TC, Yu J, Shu Y, Zou L. S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist. Leukemia. 2023 Oct;37(10):1982-1993. doi: 10.1038/s41375-023-02000-0. Epub 2023 Aug 17. PMID: 37591940. 7: Hafizi R, Imeri F, Wenger RH, Huwiler A. S1P Stimulates Erythropoietin Production in Mouse Renal Interstitial Fibroblasts by S1P1 and S1P3 Receptor Activation and HIF-2α Stabilization. Int J Mol Sci. 2021 Aug 31;22(17):9467. doi: 10.3390/ijms22179467. PMID: 34502385; PMCID: PMC8430949. 8: Jiménez-Altayó F, Marzi J, Galan M, Dantas AP, Ortega M, Rojas S, Egea G, Schenke-Layland K, Jiménez-Xarrié E, Planas AM. Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone. J Cereb Blood Flow Metab. 2022 Jan;42(1):162-174. doi: 10.1177/0271678X211033362. Epub 2021 Sep 2. PMID: 34474613; PMCID: PMC8721773. 9: Patil MJ, Meeker S, Bautista D, Dong X, Undem BJ. Sphingosine-1-phosphate activates mouse vagal airway afferent C-fibres via S1PR3 receptors. J Physiol. 2019 Apr;597(7):2007-2019. doi: 10.1113/JP277521. Epub 2019 Feb 21. PMID: 30793318; PMCID: PMC6441905. 10: Murakami A, Takasugi H, Ohnuma S, Koide Y, Sakurai A, Takeda S, Hasegawa T, Sasamori J, Konno T, Hayashi K, Watanabe Y, Mori K, Sato Y, Takahashi A, Mochizuki N, Takakura N. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. Mol Pharmacol. 2010 Apr;77(4):704-13. doi: 10.1124/mol.109.061481. Epub 2010 Jan 22. PMID: 20097776.